Cardiovascular

In 2007, SCRI launched its cardiovascular research program with the establishment of Centennial Heart as a strategic investigative site. In 2008, Steven V. Manoukian, M.D., F.A.C.C., F.S.C.A.I., came to SCRI from Emory University to lead the cardiovascular research program. In 2009, a second strategic investigative site, Redmond Regional Medical Center/Harbin Clinic, was added, and R. Christopher Jones, M.D., F.A.C.C., joined as director of electrophysiology research.

Cardiovascular research at SCRI continues the legacy of cancer research initiated in 1993 by Tennessee Oncology researchers F. Anthony Greco, M.D., director of Sarah Cannon Cancer Center, and John D. Hainsworth, M.D., chief scientific officer, who shared a vision of bringing innovative treatments to cancer patients in the communities where they lived. They co-founded the Sarah Cannon Cancer Center, which quickly became the largest privately funded, community-based cancer program in the country. In 2004, the Sarah Cannon Research Institute was formed to expand the research initiatives of the Sarah Cannon Cancer Center.

Research Excellence

SCRI is setting the standard for effectively managed, reliable clinical research trials and has a growing network of nationally recognized clinical trial management programs in association with physician practices. Our comprehensive cardiovascular research program is designed to provide state-of-the-art, innovative approaches and facilitate a wide spectrum of comprehensive and cost-effective services rarely found in today’s management of clinical trials.

Services

SCRI specializes in clinical research services for physician groups, including program development, clinical trial pipeline development, regulatory affairs, quality assurance, contracts and budgets, site management, patient recruitment and marketing support. By integrating these capabilities into our organization, SCRI is able to effectively manage the growing demand for support in managing clinical trials.

Quality and Expertise

A solid operational infrastructure, experienced management team and sound strategic vision have well positioned SCRI to provide all of its partners—physicians and pharmaceutical companies—an optimal way to conduct quality, outcome-based clinical trials.